These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 20957001)

  • 1. The metabolic actions of glucagon revisited.
    Habegger KM; Heppner KM; Geary N; Bartness TJ; DiMarchi R; Tschöp MH
    Nat Rev Endocrinol; 2010 Dec; 6(12):689-97. PubMed ID: 20957001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon regulation of energy metabolism.
    Heppner KM; Habegger KM; Day J; Pfluger PT; Perez-Tilve D; Ward B; Gelfanov V; Woods SC; DiMarchi R; Tschöp M
    Physiol Behav; 2010 Jul; 100(5):545-8. PubMed ID: 20381509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperative role of the glucagon-like peptide-1 receptor and β3-adrenergic-mediated signalling on fat mass reduction through the downregulation of PKA/AKT/AMPK signalling in the adipose tissue and muscle of rats.
    Decara J; Rivera P; Arrabal S; Vargas A; Serrano A; Pavón FJ; Dieguez C; Nogueiras R; Rodríguez de Fonseca F; Suárez J
    Acta Physiol (Oxf); 2018 Apr; 222(4):e13008. PubMed ID: 29193738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon Control on Food Intake and Energy Balance.
    Al-Massadi O; Fernø J; Diéguez C; Nogueiras R; Quiñones M
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31405212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of Glucose-dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: Implications for obesity, type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD).
    Thondam SK; Cuthbertson DJ; Wilding JPH
    Peptides; 2020 Mar; 125():170208. PubMed ID: 31759125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of leucine on energy balance.
    McAllan L; Cotter PD; Roche HM; Korpela R; Nilaweera KN
    J Physiol Biochem; 2013 Mar; 69(1):155-63. PubMed ID: 22535285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet-induced obesity.
    Nogueiras R; Pérez-Tilve D; Veyrat-Durebex C; Morgan DA; Varela L; Haynes WG; Patterson JT; Disse E; Pfluger PT; López M; Woods SC; DiMarchi R; Diéguez C; Rahmouni K; Rohner-Jeanrenaud F; Tschöp MH
    J Neurosci; 2009 May; 29(18):5916-25. PubMed ID: 19420258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon, GLP-1 and Thermogenesis.
    González-García I; Milbank E; Diéguez C; López M; Contreras C
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31337027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brown Adipose Tissue: A New Potential Target for Glucagon-like Peptide 1 Receptor Agonists in the Treatment of Obesity.
    Hropot T; Herman R; Janez A; Lezaic L; Jensterle M
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The physiological and pathophysiological roles of taurine in adipose tissue in relation to obesity.
    Murakami S
    Life Sci; 2017 Oct; 186():80-86. PubMed ID: 28801262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new glucagon and GLP-1 co-agonist eliminates obesity in rodents.
    Day JW; Ottaway N; Patterson JT; Gelfanov V; Smiley D; Gidda J; Findeisen H; Bruemmer D; Drucker DJ; Chaudhary N; Holland J; Hembree J; Abplanalp W; Grant E; Ruehl J; Wilson H; Kirchner H; Lockie SH; Hofmann S; Woods SC; Nogueiras R; Pfluger PT; Perez-Tilve D; DiMarchi R; Tschöp MH
    Nat Chem Biol; 2009 Oct; 5(10):749-57. PubMed ID: 19597507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of glucagon, epinephrine and insulin on in vitro lipolysis of adipose tissue from mammals and birds.
    Prigge WF; Grande F
    Comp Biochem Physiol B; 1971 May; 39(1):69-82. PubMed ID: 5570026
    [No Abstract]   [Full Text] [Related]  

  • 13. Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primates.
    Henderson SJ; Konkar A; Hornigold DC; Trevaskis JL; Jackson R; Fritsch Fredin M; Jansson-Löfmark R; Naylor J; Rossi A; Bednarek MA; Bhagroo N; Salari H; Will S; Oldham S; Hansen G; Feigh M; Klein T; Grimsby J; Maguire S; Jermutus L; Rondinone CM; Coghlan MP
    Diabetes Obes Metab; 2016 Dec; 18(12):1176-1190. PubMed ID: 27377054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S 23521 decreases food intake and body weight gain in diet-induced obese rats.
    Claret M; Corominola H; Canals I; Nadal B; Chavanieu A; Pfeiffer B; Renard P; Gorostiaga C; Delagrange P; Grassy G; Gomis R
    Obes Res; 2004 Oct; 12(10):1596-603. PubMed ID: 15536223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity.
    Flint A; Raben A; Ersbøll AK; Holst JJ; Astrup A
    Int J Obes Relat Metab Disord; 2001 Jun; 25(6):781-92. PubMed ID: 11439290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of obesity and related pathologies: transcriptional control of adipose tissue development.
    Vernochet C; Peres SB; Farmer SR
    FEBS J; 2009 Oct; 276(20):5729-37. PubMed ID: 19754874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interaction between insulin and glucagon].
    Koyama S; Abe M
    Nihon Naibunpi Gakkai Zasshi; 1970 Nov; 46(8):881-2. PubMed ID: 4321465
    [No Abstract]   [Full Text] [Related]  

  • 18. GIP receptor deletion in mice confers resistance to high-fat diet-induced obesity via alterations in energy expenditure and adipose tissue lipid metabolism.
    Boer GA; Keenan SN; Miotto PM; Holst JJ; Watt MJ
    Am J Physiol Endocrinol Metab; 2021 Apr; 320(4):E835-E845. PubMed ID: 33645252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic response to a glucagon challenge varies with adiposity and life-history stage in fasting northern elephant seals.
    Crocker DE; Fowler MA; Champagne CD; Vanderlugt AL; Houser DS
    Gen Comp Endocrinol; 2014 Jan; 195():99-106. PubMed ID: 24239794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liraglutide treatment counteracts alterations in adipose tissue metabolism induced by orchiectomy in rats.
    Model JFA; Lima MV; Ohlweiler R; Sarapio E; Vogt ÉL; Rocha DS; de Souza SK; Vinagre AS
    Life Sci; 2021 Aug; 278():119586. PubMed ID: 33957171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.